Cian McCarthy
@CianPMcCarthy
Followers
3K
Following
10K
Media
153
Statuses
1K
Cardiologist @MGHHeartHealth | Former IM Resident @MGHMedicine & CV fellow @MGHCVFELLOWS | Alum: @UCC | Irish ☘️ | Opinions are my own
Boston
Joined December 2017
assessment and management of patients with type 2 myocardial infarction: an international Delphi study
academic.oup.com
AbstractAims. Type 2 myocardial infarction due to myocardial oxygen supply–demand imbalance is associated with poor outcomes. There are no guidelines to in
0
0
1
RT @SABOURETCardio: Rationale and design of the REMBRANDT trial: A phase 3 study to evaluate the effect of #obicetrapib/ezetimibe on corona….
0
3
0
The most fun image & video creation tool in the world is here. Try it for free in the Grok App.
0
205
2K
RT @InbarMcCarthy: AQUATIC .In pts with CAD (>6 months after stent) and AF, OAC alone resulted in less major bleeding and less MACE/CV deat….
nejm.org
The appropriate antithrombotic regimen for patients with chronic coronary syndrome who are at high atherothrombotic risk and receiving long-term oral anticoagulation remains unknown. We conducted a...
0
1
0
RT @InbarMcCarthy: A couple more important studies at #ESCCongress2025 1/4.
0
1
0
RT @MitsuakiSawano: 2️⃣ Obicetrapib and Cardiovascular Outcomes. BROADWAY NEJM. https://t.c….
0
1
0
RT @InbarMcCarthy: DAPA ACT HF TIMI 68 negative trial on inpatient SGLT2i initiation (possibly due to short 2 month follow up and low event….
0
1
0
RT @InbarMcCarthy: Conflicting data from REBOOT and BETAMI-DANBLOCK regarding use of beta blockers after MI in preserved LVEF (both publish….
0
1
0
RT @InbarMcCarthy: MAPLE-HCM shows Aficamten monotherapy superior to metoprolol monotherapy in symptomatic oHCM patients in improving exerc….
0
1
0
RT @JACCJournals: BP 139/89 = “normal” BP 140/90 = “disease” Same with cholesterol. These binary thresholds are outdated & misleading https….
0
34
0
RT @JAMACardio: In this Viewpoint, @CianPMcCarthy and colleagues advocate for cardiovascular disease outcome trials for new BP lowering tre….
0
4
0
Implementing the 2025 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Leveraging Evidence to Push the Boundaries of Clinical Care | Hypertension
ahajournals.org
1
2
7
RT @medpagetoday: Blood pressure (BP) guidelines moved the bar lower for hypertension treatment, among other changes in the first national….
medpagetoday.com
AHA/ACC recommendations also switch to the PREVENT risk calculator
0
1
0
RT @HeartDocSadiya: Amazing to see this new set of guidelines out with advances including earlier treatment, focus on sex-specific BP risk….
0
16
0
RT @AniruddhPatelMD: 🚨 Excited to share our new manuscript in @circAHA led by @BellomoTiffany and team. We evaluated lipoprotein(a) as a pr….
0
20
0
RT @TCTMD_Yael: For symptomatic patients who’ve undergone CCTA, added knowledge gleaned from AI-CPA (@Heartflow) changes the management str….
tctmd.com
The technology, which led to a shift in strategy more than half of the time, could save $719 per symptomatic patient over 10 years.
0
3
0
0
0
1
Obicetrapib is a selective CETPi which ⏬ LDL-C by ~36%. Now in @AmericanHeartJ, we discuss the rational/design of the phase 3 REMBRANDT trial which will examine the effect of obicetrapib + ezetimibe on coronary plaque. @JohnKastelein @ProfSNicholls
1
7
25